Mei Qiu

20PUBLICATIONS
3CO-AUTHORS
Molecular targetsPharmacogenomicsMedical genetics (excl. cancer genetics)Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 30, 2021
Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial.

Li-Min Zhao, Ze-Lin Zhan, Mei Qiu

|Jul 07, 2021
Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs.

Mei Qiu, Liang-Liang Ding, Hai-Rong Zhou

|May 24, 2021
Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials.

Dao-Gen Yin, Liang-Liang Ding, Hai-Rong Zhou

|Apr 23, 2021
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors.

Mei Qiu, Liang-Liang Ding, Miao Zhang

|Feb 09, 2021
Use of SGLT2 inhibitors and occurrence of noninfectious respiratory disorders: a meta-analysis of large randomized trials of SGLT2 inhibitors.

Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan

|Aug 28, 2020
GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression.

Mei Qiu, Liang-Liang Ding, Miao Zhang

Pageof 4

Frequent Collaborators

9 joint publications

Liang-Liang Ding

2 joint publications

Shu-Yan Liu

1 joint publications

Lixin Du